Skip to main content

Table 4 Patient characteristics who developed vaginal ulcer

From: Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies

Patient no.

Age at HDR-ISBT*

Primary site

Prior pelvic RT

Interval between prior RT and HDR-ISBT*(mo)

HDR-ISBT*with/without EBRT††

Total vaginal wall D0.5cc#/D1cc#/D2cc#in EQD2##(Gy)

LENT SOMAobjective score

LENT SOMAmanagement score

1

40

Cervix

WPRT 45 Gy/25fr + EBRT†† boost 15 Gy/5fr

27

HDR-ISBT* 36 Gy/9fr

272.1/202.6/169.1

4

4

2

51

Cervix

None

None

WPRT 30 Gy/15fr + CS|| 20 Gy/10fr + HDR-ISBT* 24 Gy/4fr

215.2/171.8/145.4

4

3

3

64

Corpus

None

None

WPRT 30 Gy/15fr + HDR-ISBT* 30 Gy/5fr

196.6/141.5/109.1

2

1

4

64

Cervix

WPRT 40 Gy/20fr + CS 10 Gy/5 + HDR-ICBT 18 Gy/3fr

40

HDR-ISBT* 48 Gy/8fr

465.4/352.1/294.4

2

1

5

67

Cervix

WPRT 50 Gy/50fr + HDR-ICBT 12 Gy/3fr

15

HDR-ISBT* 42 Gy/7fr

234.0/211.1/193.5

4

3

  1. *HDR-ISBT: high-dose-rate interstitial brachytherapy.
  2. WPRT: whole pelvis radiation therapy.
  3. ††EBRT: external beam radiation therapy.
  4. ||CS: radiation therapy with center shielding.
  5. LENT-SOMA: Late Effects of Normal Tissues - Subjective, Objective, Management, Analytic.
  6. #D0.5cc, D1cc, D2cc: most exposed 0.5, 1 and 2 cm3 of tissue.
  7. ##EQD2: equivalent dose in 2 Gy fractions.